SCHEMBL18853025

SCHEMBL18853025

c1ccc(-c2ccc(-c3cccc(-c4cccc(-c5nc(-c6ccccc6)nc6c5sc5ccc7ccccc7c56)c4)c3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 2/20 0.38
CYP1A1 P04798 2/20 0.35
CYP1B1 Q16678 2/20 0.35
PIK3CA P42336 1/20 0.35
PI4KA P42356 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ATM Q13315 1/20 0.34
RORB Q92753 1/20 0.34
PIM1 P11309 2/20 0.34
PIM2 Q9P1W9 2/20 0.34
PIM3 Q86V86 1/20 0.34
CYP1A2 P05177 1/20 0.33
LMNA P02545 3/20 0.33
MAPT P10636 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
RECQL P46063 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18853023 0.99 CYP1A1 (0.36) LIMK1CYP1A1CYP1B1PIK3CAPI4KA
SCHEMBL18852930 0.99 CYP1A1 (0.36) LIMK1CYP1A1CYP1B1PIK3CAPI4KA
SCHEMBL18853035 0.98 CYP1A1 (0.35) LIMK1CYP1A1CYP1B1PIK3CAPI4KA
SCHEMBL18853057 0.96 CYP1A1 (0.36) LIMK1CYP1A1CYP1B1PIK3CAPI4KA
SCHEMBL18853036 0.95 LIMK1 (0.38) LIMK1CYP1A1CYP1B1PIK3CAPI4KA
SCHEMBL18853043 0.94 CYP1A1 (0.36) LIMK1CYP1A1CYP1B1PIK3CAPI4KA
SCHEMBL18852881 0.94 CYP1A1 (0.36) LIMK1CYP1A1CYP1B1PIK3CAPI4KA
SCHEMBL18853006 0.94 CYP1A1 (0.36) LIMK1CYP1A1CYP1B1PIK3CAPI4KA
SCHEMBL18852923 0.93 CYP1A1 (0.35) LIMK1CYP1A1CYP1B1PIK3CAPI4KA
SCHEMBL18853028 0.93 MEN1 (0.40) LIMK1CYP1A1CYP1B1PIK3CAPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680190-B2 Organic compound, organic optoelectronic element, and display device SAMSUNG SDI CO., LTD. (KR) 2020-06-09 US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 LIMK1 230/4885CYP1A1 108/4885CYP1B1 70/4885
US-10680190-B2 Organic compound, organic optoelectronic element, and display device OCIAD1, OXER1, OCIAD2 LIMK1 230/4885CYP1A1 108/4885CYP1B1 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.